Accelerate to discover
Related topics
Micro-CT: Fancy gadget or indispensable technology towards quantification of lung diseases?
Jul 29, 2020
Technology allowing evaluation of live animals repeatedly is indispensable to gain better insight into the dynamics of...
Breakthrough discoveries from shear flow assays for Platelet biology and vascular studies
Jul 17, 2020
After a short introduction on the physio-pathological roles of platelets and the importance of their cell adhesion...
Hybrid PET/MR enables exploration of new science
Jul 14, 2020
Watch the recorded webinar on PET/MR, driven by Peter Caravan at MGH for the application part, during which the launch...
IncuCyte webinar: Advances in 3D cell models for cancer biology
Jul 1, 2020
Get answers to your questions on 3D spheroid-based drug discovery, organoid research and working with advanced cell...
MicroCT Applications in Lung research and Immunology
Jun 22, 2020
The ability to monitore and quantitate lung disease in real time is an advantage to using small animal microCT. Also,...
Saphyr identifies all variants detected by the standard of care in cytogenetics
Jun 1, 2020
Cancer genomics consortium members demonstrate 100% concordance between Bionano Genomics optical mapping technology and...
Webinar recording: Isolating ultra-high molecular weight (UHMW) DNA for genome analysis
May 12, 2020
Watch the webinar from Bionano Genomics and learn the tips and tricks for isolating high quality UHMW DNA - right from...
Isoflux webinar: Accurate liquid biopsy approach reveals mutations in lung cancer patients
Apr 29, 2020
Liquid biopsies aim to identify clinically actionable information from cell-free DNA (cfDNA) and circulating tumor...
Nov 22, 2018
Researchers developed an assay to measure CLL cell interactions with endothelium under shear force using a Bioflux 200 and blocked CD62L using the anti-CD62L antibody DREG-56. CLL cell interactions with endothelium were visualized by time-lapse microscopy and CLL cell movement was tracked and quantified. Data will be discussed in the webinar and will establish targeting CD62L inhibits CLL cell/endothelial cell interactions and is accentuated by co-administration with ibrutinib. These data imply that some of the clinical effects caused by ibrutinib are due to a reduced capacity of CLL cells to engage endothelium and extravasate.
Dr. Chris Pepper, Professor in Cancer Studies, University of Sussex, UK
Related technologies: Cell interaction studies
Get more info
Brand profile
With BioFlux System for live cell analysis under shear flow and IsoFlux System for circulating tumor cell analysis, Fluxion Biosciences turn power of benchtop cellular analysis with advanced tools to automate complex assays.
More info at:
www.fluxionbio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
